Related Experiment Video
Updated: Jun 19, 2026

Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope
Published on: March 24, 2017
ON THE SEROLOGICAL SPECIFICITY OF PEPTIDES. III
K Landsteiner1, J van der Scheer
1Laboratories of The Rockefeller Institute for Medical Research.
Antibodies in immune sera recognize entire pentapeptides, not just parts. Differences between peptide and amide structures significantly impact serological specificity.
Area of Science:
- Immunology
- Biochemistry
- Peptide Chemistry
Background:
- Immune sera are crucial for studying antibody-antigen interactions.
- Understanding antibody specificity is key to developing diagnostics and therapeutics.
- Pentapeptides and their amide counterparts offer a model system to probe antibody recognition.
Purpose of the Study:
- To investigate the specificity of antibodies generated against pentapeptides.
- To determine if antibodies recognize specific portions or the entire peptide sequence.
- To compare the serological reactivity of peptides versus their corresponding amides.
Main Methods:
- Production of immune sera against pentapeptides.
- Absorption and inhibition assays to analyze antibody binding.
- Comparative analysis of peptide and amide reactions with immune sera.
Main Results:
- Antibodies in immune sera demonstrated specificity for the entire pentapeptide sequence.
- No evidence of antibodies recognizing only specific peptide fragments was found.
- Significant differences in serological reactions were observed between peptides and their corresponding amides.
Conclusions:
- Antibody recognition of pentapeptides is holistic, targeting the complete molecule.
- The presence and nature of polar groups, such as acid versus amide termini, critically influence serological specificity.
More Related Videos
09:32Immunopeptidomics: Isolation of Mouse and Human MHC Class I- and II-Associated Peptides for Mass Spectrometry Analysis
Published on: October 15, 2021
11:10Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study
Published on: June 29, 2016